Clinical Trial Update: Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of adalimumab in pediatric patients with moderate to severe ulcerative colitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: AbbVie | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2020-10-05